Category: Defective Drugs
Texas Kombiglyze Class Action Lawyer
AstraZeneca’s new type-2 diabetes drug Kombiglyze may increase a user's risk of heart failure, pancreatitis, pancreatic cancer, rhabdomyolysis, and other side effects.
Texas Kombiglyze Heart Failure Lawyer
AstraZeneca’s Kombiglyze contains saxagliptin, a new diabetes drug that has been linked to increased rates of hospitalization for heart failure and deaths.
Texas Onglyza Pancreatic Cancer Lawyer
The FDA is investigating the risk of pancreatic cancer from Onglyza, a new type-2 diabetes drug made by AstraZeneca.
Texas Onglyza Class Action Lawyer
Onglyza has been linked to life-threatening side effects, such as pancreatitis, pancreatic cancer, heart failure, rhabdomyolysis, and more.
FDA Strengthens Heart Attack Warnings on NSAID Painkillers
July 10, 2015 -- The FDA is strengthening warnings about the risk of heart attack and stroke from painkillers in the non-steroidal anti-inflammatory drug (NSAID) class. NSAIDs include ibuprofen (Advil, Motrin), naproxen (Aleve), and celecoxib (Celebrex). They are used to...
Zofran Clubfoot Lawsuit Filed in New Jersey
July 10, 2015 -- A lawsuit has been filed against GlaxoSmithKline (GSK) by the parents of a boy who was born with clubfoot after his mother took the anti-nausea drug Zofran during pregnancy. Zofran (ondansetron) is a chemotherapy drug that...
Study Confirms Paxil and Prozac Increase Risk of Birth Defects
July 9, 2015 -- When women use the antidepressants Paxil or Prozac just before or during the first three months of pregnancy, they may double or triple the risk of having a baby with certain birth defects. Those were the...
Health Groups Sue FDA for Sovaldi/Harvoni Clinical Trial Data
July 9, 2015 -- Two public health groups have sued the FDA to obtain access to the information Gilead Sciences submitted to gain approval for Harvoni and Sovaldi, two new hepatitis C drugs. The drugs are more than 90% effective...
Drug-Maker Asks Judges to Centralize Zofran Lawsuits in MDL
July 7, 2015 -- GlaxoSmithKline (GSK) has asked a panel of federal judges to centralize twelve lawsuits involving the anti-nausea drug Zofran into one federal court in Pennsylvania. In a motion(PDF) filed July 6 with the U.S. Judicial Panel on...
FDA Reviewing Safety of Codeine Cough Syrup for Kids
July 2, 2015 -- The FDA is evaluating the safety of cough syrups for children that contain codeine due to the risk of serious side effects, including slowed breathing and death. The announcement came after the European Medicines Agency (EMA)...